跳至主要内容
临床试验/NCT07168551
NCT07168551尚未招募不适用

Association of Hyperuricemia and Non Alcoholic Fatty Liver Disease and Liver Fibrosis Risk in Adult Obese Patients

Assiut University0 个研究点目标入组 111 人开始时间: 2025年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
111
主要终点
Prevalence of NAFLD

研究概览

简要总结

  1. Identifying the association between hyperuricemia and NAFLD can lead to early detection and prevention of liver fibrosis in adult obese patients.
  2. Understanding the relationship between hyperuricemia and NAFLD can inform targeted therapy, such as urate-lowering treatment, to potentially slow disease progression.

3 - To examine the relationship between serum uric acid levels and liver fibrosis severity*: Assessing the correlation between serum uric acid levels and the severity of liver fibrosis in adult obese patients with NAFLD.

4- To identify potential mechanisms underlying the association*: Exploring the potential mechanisms by which hyperuricemia may contribute to the development and progression of NAFLD and liver fibrosis in adult obese patients.

详细描述

Hyperuricemia is associated with nonalcoholic fatty liver disease (NAFLD), whereas whether the association differed by hyperuricemia onset age remained unclear. This study sought to investigate the associations of hyperuricemia onset age with the risk of incident NAFLD across adulthood.

Obesity has been demonstrated to show a consistent link with the increased possibility of nonalcoholic fatty liver disease (NAFLD). Since both serum uric acid (SUA) and obesity are essential components of metabolic syndrome (MetS), it is uncertain whether the incidence of NAFLD results from serum uric acid, obesity, or other potential factors based on previous studies.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age: Adults (typically 18-65 years old)
  • 2 - Body Mass Index (BMI): Obese patients with a BMI ≥ 30 kg/m²
  • 3- Hyperuricemia : Elevated serum uric acid levels (typically > 7 mg/dL for men and > 6 mg/dL for women)

排除标准

  • excessive alcohol consumption ( > 20 gm /day in men and 10 in g /day in women )
  • 2- use of steatogenic within the past 6 months
  • 3- positive test for hepatitis B surface antigen and hepatitis B core antibody
  • 4- Drug induced liver injury and autoimmune hepatitis
  • 5 - cirrhosis and other causes of liver disease

结局指标

主要结局

Prevalence of NAFLD

时间窗: 1 year

The proportion of adult obese patients with NAFLD in the study population

次要结局

  • Serum uric acid level(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Aya Adel Mahmoud Abu Shady

Internal medicine Resident doctor

Assiut University

相似试验